Identifying and characterising potential new therapeutic agents to target cell proliferation may provide improved treatments for neoplastic disorders such as cancer and polycystic diseases.
Naringenin inhibits the growth of Dictyostelium and MDCK-derived cysts in a polycystin-2 (TRPP2)-dependent manner.
Creators
A Waheed
MH Ludtmann
N Pakes
S Robery
A Kuspa
C Dinh
D Baines
RS Williams
MA Carew
Publication Details
Br J Pharmacol
Date published
03/10/2013
Date submitted
17/05/2017
Identifiers
99511924002346
Academic Unit
University of Surrey
Language
English
Resource Type
Journal article
Usage Policy
Usage details for all content viewed and downloaded in this site are shared with IRUS-UK (Institutional Repository Usage Statistics UK). Cookies are used to remember your decision. Click Accept to accept usage details sharing and the cookies.